Home › Funds › DIADEMA PARTNERS LP › CAPR

DIADEMA PARTNERS LP position in CAPR

CAPRICOR THERAPEUTICS INC COM NEW · Health Care

DIADEMA PARTNERS LP reported holding 329,300 shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW) in its Q2 2026 13F filing — a position valued at US$7.9M, representing 1.72% of its reported portfolio and ranking #18 among its reported holdings. DIADEMA PARTNERS LP has disclosed CAPR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)329.30K sh
Reported value held$7.93M
Portfolio Weight1.72%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DIADEMA PARTNERS LP's CAPR position evolved

DIADEMA PARTNERS LP first disclosed a stake in CAPR in Q4 2024 at 58,700 shares (US$810K). The position peaked in Q2 2026 at 329,300 shares, worth US$7.9M. Across 7 filings, DIADEMA PARTNERS LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 329,300 shares valued at US$7.9M — an increase of 250,449 shares quarter over quarter.. Notable position changes include a 252% increase in Q2 2025 (shares fell 27% over the following quarter), a 181% increase in Q3 2025 (shares rose 300% over the following quarter), a 318% increase in Q2 2026 (shares fell 61% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 58.70K $810.06K New
Q1 2025 30.30K $287.55K Reduce
Q2 2025 106.60K $1.06M Add
Q3 2025 300.00K $2.16M Add
Q4 2025 158.07K $4.56M Reduce
Q1 2026 78.85K $2.40M Reduce
Q2 2026 329.30K $7.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CAPR and 13F data

CAPR (CAPRICOR THERAPEUTICS INC COM NEW) is a Health Care company. 64 other funds we track also report a position in CAPR — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$98.7M), MONTANOVA CAPITAL, LLC (US$98.6M), RA CAPITAL MANAGEMENT, L.P. (US$36.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CAPR

All CAPR fund holders →

FAQ

How long has DIADEMA PARTNERS LP held CAPR?

DIADEMA PARTNERS LP has disclosed CAPR holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is DIADEMA PARTNERS LP's current position in CAPR?

As of Q2 2026, DIADEMA PARTNERS LP holds 329.30K shares of CAPR (CAPRICOR THERAPEUTICS INC COM NEW), valued at $7.93M, representing 1.72% of its reported portfolio and ranking #18.

Has DIADEMA PARTNERS LP been buying or selling CAPR?

In the latest 13F filing (Q2 2026), DIADEMA PARTNERS LP increased its position in CAPR. The position peaked in Q2 2026 at 329.30K shares.

Which other funds hold CAPR?

Other major institutional holders of CAPR include TANG CAPITAL MANAGEMENT LLC, MONTANOVA CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.